![Jeffrey Behrens](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jeffrey S.
Behrens is the founder of Telluride Group, founded in 1995.
Mr. Behrens is the founder of LabShares Newton LLC, founded in 2018, holding the title of Director.
Mr. Behrens is currently a Director at Savran Technologies, Inc. Former positions include President, Chief Executive Officer & Director at Siamab Therapeutics, Inc., President, Chief Executive Officer & Treasurer at GelMEDIX, Inc., Director-Strategic Alliances at Alnylam Pharmaceuticals, Inc., Senior Director-Business Development & Operations at Edimer Pharmaceuticals, Inc., Head-Business Operations at Biogen, Inc., Principal at Escoublac, Inc., and Member at Launchpad Venture Group LLC.
| Sociétés | Poste | Début |
|---|---|---|
Telluride Group
 Telluride Group Information Technology ServicesTechnology Services Provides managed information technology (IT) services | Fondateur | 02/06/2010 |
Savran Technologies, Inc.
 Savran Technologies, Inc. BiotechnologyHealth Technology Develops and provides non-invasive diagnostics based on capture & analysis of rare cells | Directeur/Membre du Conseil | - |
| Sociétés | Poste | Fin |
|---|---|---|
Escoublac, Inc.
 Escoublac, Inc. BiotechnologyHealth Technology Offers treatment for obesity and related disorders | Corporate Officer/Principal | 31/08/2012 |
GelMEDIX, Inc.
 GelMEDIX, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as an ocular cell therapy company | Directeur Général | - |
Labshares Newton LLC
 Labshares Newton LLC Real Estate DevelopmentFinance Rents office space and laboratory incubator for biotechnology and life science start-ups | Fondateur | - |
Siamab Therapeutics, Inc.
 Siamab Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops prognostic and diagnostic tools to identify N-glycolylneuraminic Acid (Gc) contamination | Directeur Général | - |
| BIOGEN INC. | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 10 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Siamab Therapeutics, Inc.
Siamab Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops prognostic and diagnostic tools to identify N-glycolylneuraminic Acid (Gc) contamination | Health Technology |
Escoublac, Inc.
Escoublac, Inc. BiotechnologyHealth Technology Offers treatment for obesity and related disorders | Health Technology |
Alnylam Pharmaceuticals, Inc.
 Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
Telluride Group
Telluride Group Information Technology ServicesTechnology Services Provides managed information technology (IT) services | Technology Services |
Launchpad Venture Group LLC
 Launchpad Venture Group LLC Investment ManagersFinance Launchpad Venture Group invests in companies located in the United States and the United Kingdom. The firm focuses on technology and life sciences sectors. It participates in early stage capital transactions. | Finance |
Edimer Pharmaceuticals, Inc.
 Edimer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides biopharmaceutical products for improving the health and quality of life of families living with XLHED | Health Technology |
Savran Technologies, Inc.
Savran Technologies, Inc. BiotechnologyHealth Technology Develops and provides non-invasive diagnostics based on capture & analysis of rare cells | Health Technology |
Labshares Newton LLC
Labshares Newton LLC Real Estate DevelopmentFinance Rents office space and laboratory incubator for biotechnology and life science start-ups | Finance |
GelMEDIX, Inc.
GelMEDIX, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as an ocular cell therapy company | Commercial Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
